Transcatheter Pulmonary Valve Replacement: Current State of Art

Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • 145 Downloads
Part of the following topical collections:
  1. Topical Collection on Structural Heart Disease

Abstract

Purpose of Review

The past couple of decades have brought tremendous advances to the field of pediatric and adult congenital heart disease (CHD). Percutaneous valve interventions are now a cornerstone of not just the congenital cardiologist treating patients with congenital heart disease, but also—and numerically more importantly—for adult interventional cardiologists treating patients with acquired heart valve disease. Transcatheter pulmonary valve replacement (tPVR) is one of the most exciting recent developments in the treatment of CHD and has evolved to become an attractive alternative to surgery in patients with right ventricular outflow tract (RVOT) dysfunction. This review aims to summarize (1) the current state of the art for tPVR, (2) the expanding indications, and (3) the technological obstacles to optimizing tPVR.

Recent Findings

Since its introduction in 2000, more than ten thousands tPVR procedures have been performed worldwide. Although the indications for tPVR have been adapted earlier from those accepted for surgical intervention, they remain incompletely defined. The new imaging modalities give better assessment of cardiac anatomy and function and determine candidacy for the procedure. The procedure has been shown to be feasible and safe when performed in patients who received pulmonary conduit and or bioprosthetic valves between the right ventricle and the pulmonary artery. Fewer selected patients post trans-annular patch repair for tetralogy of Fallot may also be candidates for this technology. Size restrictions of the currently available valves limit deployment in the majority of patients post trans-annular patch repair. Newer valves and techniques are being developed that may help such patients.

Summary

Refinements and further developments of this procedure hold promise for the extension of this technology to other patient populations.

Keywords

Congenital heart disease Tetralogy of Fallot Pulmonary stenosis Pulmonary regurgitation Right ventricular outflow tract dysfunction Transcatheter pulmonary valve replacement 

Notes

Compliance with Ethical Standards

Conflict of Interest

Wail Alkashkari and Amani Alsubei declare that they have no conflict of interest.

Ziyad M. Hijazi is a consultant for Venus Medtech.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Supplementary material

11886_2018_966_MOESM1_ESM.docx (24 kb)
ESM 1 (DOCX 24kb).
11886_2018_966_MOESM2_ESM.pptx (1.2 mb)
ESM 2 (PPTX 1.14mb).
11886_2018_966_MOESM3_ESM.pptx (1.2 mb)
ESM 3 (PPTX 1.15mb).
11886_2018_966_MOESM4_ESM.pptx (3.4 mb)
ESM 4 (PPTX 3.38mb).
11886_2018_966_MOESM5_ESM.pptx (1.2 mb)
ESM 5 (PPTX 1.15mb).

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. 1.
    Verheugt CL, Uiterwaal C, van der Velde ET, Meijoom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Ong K, Boone R, Gao M, Carere R, Webb J, Kiess M, et al. Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol. 2013;111(11):1638–43.PubMedCrossRefGoogle Scholar
  3. 3.
    Boethig D, Thies WR, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras. Eur J Cardiothorac Surg. 2005;27(1):58–66.PubMedCrossRefGoogle Scholar
  4. 4.
    Elahi M, Dhannapuneni R, Firmin R, Hickey M. Direct complications of repeat median sternotomy in adults. Asian Cardiovasc Thorac Ann. 2005;13(2):135–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Temeck BK, Katz NM, Wallace RB. An approach to reoperative median sternotomy. J Card Surg. 1990;5(1):14–25.PubMedCrossRefGoogle Scholar
  6. 6.
    Daebritz SH. Update in adult congenital cardiac surgery. Pediatr Cardiol. 2007;28(2):96–104.PubMedCrossRefGoogle Scholar
  7. 7.
    van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di Donato R, et al. Risk of surgery for congenital heart disease in the adult: a multi-centered European study. Ann Thorac Surg. 2007;83(1):161–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Verheugt CL, Uiterwaal CS, Grobbee DE, Mudler BG. Long-term prognosis of congenital heart defects: a systematic review. Int J Cardiol. 2008;131(1):25–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122(9):868–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Coats L, Tsang V, Khambadkone S, van Doorn C, Cullen S, Deanfield J, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg. 2005;27(4):536–43.PubMedCrossRefGoogle Scholar
  13. 13.
    Aboulhosn JA, Lluri G, Gurvitz MZ, Khairy P, Mongeon FP, Kay J, et al. Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol. 2013;29(7):866–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Fernandes FP, Manlhiot C, Roche SL, Grosse-Wortmann L, Slorach C, McCrindle BW, et al. Impaired left ventricular myocardial mechanics and their relation to pulmonary regurgitation, right ventricular enlargement and exercise capacity in asymptomatic children after repair of tetralogy of Fallot. J Am Soc Echocardiogr. 2012;25(5):494–503.PubMedCrossRefGoogle Scholar
  15. 15.
    Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factor for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356(9234):975–81.PubMedCrossRefGoogle Scholar
  16. 16.
    Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams DH. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 2005;80(3):845–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Garatti A, Nano G, Bruschi G, et al. Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg. 2012;93(4):1146–53.PubMedCrossRefGoogle Scholar
  18. 18.
    Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:9.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.PubMedCrossRefGoogle Scholar
  20. 20.
    Silversides CK, Marelli A, Beauchesen L, Dore A, Kiess M, Salehian O, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol. 2010;26:143–50.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.PubMedCrossRefGoogle Scholar
  22. 22.
    Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tract conduits: early results from the U.S. clinical trial. J Am Coll Cardiol. 2009;54:1722–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Borik S, Crean A, Horlick E, Osten M, Lee KJ, Chaturvedi R, et al. Percutaneous pulmonary valve implantation: 5 years of follow-up: does age influence outcomes? Circ Cardiovasc Interv. 2015;8(2):e001745.PubMedCrossRefGoogle Scholar
  24. 24.
    Aboulhosn J, Levi DS. Percutaneous pulmonary valve implantation: is earlier valve implantation better? Circ Cardiovasc Interv. 2015;8(2):e002260.PubMedCrossRefGoogle Scholar
  25. 25.
    Berman DP, McElhinney DB, Vincent JA, Hellenbrand WE, Zahn EM. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits. Circ Cardiovasc Interv. 2014;7:142–8.PubMedCrossRefGoogle Scholar
  26. 26.
    McElhinney DB, Hellenbrand WE, Zahn EM, Jones TK, Cheatham JP, Lock JE, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507–16.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58:2248–56.PubMedCrossRefGoogle Scholar
  28. 28.
    Wadia SK, Kenny D, Alkashkari W, Matella T, Kavinsky CJ, Hijazi ZM. Extended application of self-fabricated covered stents for interventions in adults with congenital heart disease. J Struct Heart Dis. 2016;2(3):79–86.CrossRefGoogle Scholar
  29. 29.
    AlkashkariW, Cao QL, Kavinsky CJ, Hijazi ZM. Percutaneous pulmonary valve implantation for RVOT Defect. Cardiac Intervention Today. September/October 2010.Google Scholar
  30. 30.
    AlBugami S, Althobaiti MW, Alrahemi J, Alsaiedi AJ, AlKashkari W. Coronary intervention of an anomalous left main coronary artery arising from the right sinus of valsalva presented as acute coronary syndrome. J Cardiol Curr Res. 2016;5(6):00184.Google Scholar
  31. 31.
    Morray BH, McElhinney DB, Cheatham JP, Zahn EM, Berman DP, Sullivan PM, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6(5):535–42.PubMedCrossRefGoogle Scholar
  32. 32.
    Sridharan S, Coats L, Khambadkone S, Taylor AM, Bonhoeffer P. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation. 2006;113(25):e934–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Biermann D, Schönebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg. 2012;94:e7–9.PubMedCrossRefGoogle Scholar
  34. 34.
    McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011;4:602–14.PubMedCrossRefGoogle Scholar
  35. 35.
    Alkashkari W, Balan P, Heitschmidt M, Kavnisky CJ, Hijazi ZM. Pre-closure of femoral venous access sites used for very large-sized sheath insertion with Perclose device in adults undergoing cardiac intervention. Catheter Cardiovasc Interv. 2010;76(1):S3–S36.CrossRefGoogle Scholar
  36. 36.
    McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292–300.PubMedCrossRefGoogle Scholar
  37. 37.
    Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–97.PubMedCrossRefGoogle Scholar
  38. 38.
    • Cheatham JP, Hellenbrand WE, Zahn EM, Jones TK, Berman DP, Vincent JA, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131:1960–70. This study prove that tPVR with the Melody valve provided good hemodynamic and clinical outcomes up to 7 years after implantation Stent fracture was the most common cause of valve dysfunction.PubMedCrossRefGoogle Scholar
  39. 39.
    Jones TK, Rome JJ, Armstrong AK, Berger F, Hellenbrand WE, Cabalka AK, et al. Transcatheter pulmonary valve replacement reduces tricuspid regurgitation in patients with right ventricular volume/pressure overload. J Am Coll Cardiol. 2016;68:1525–35.PubMedCrossRefGoogle Scholar
  40. 40.
    Haas NA, Moysich A, Neudorf U, Mortezaeian H, Abdel-Wahab M, Schneider H, et al. Percutaneous implantation of the Edwards SAPIEN pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol. 2013;102:119–28.PubMedCrossRefGoogle Scholar
  41. 41.
    Wilson WM, Benson LN, Osten MD, Shah A, Horlick EM. Transcatheter pulmonary valve replacement with the Edwards Sapien system: the Toronto experience. JACC Cardiovasc Interv. 2015;8(14):1819–27.PubMedCrossRefGoogle Scholar
  42. 42.
    Faza N, Kenny D, Kavinsky C, Amin Z, Heitschmidt M, Hijazi ZM. Single-center comparative outcomes of the Edwards SAPIEN and Medtronic Melody transcatheter heart valves in the pulmonary position. Catheter Cardiovasc Interv. 2013;82:E535–41.PubMedGoogle Scholar
  43. 43.
    Chowdhury SM, Hijazi ZM, Rhodes J, et al. Early echocardiographic changes after percutaneous implantation of the Edwards SAPIEN transcatheter heart valve in the pulmonary position. Echocardiography. 2013;30:786–93.PubMedCrossRefGoogle Scholar
  44. 44.
    Gatlin SW, Kim DW, Mahle WT. Cost analysis of percutaneous pulmonary valve replacement. Am J Cardiol. 2011;108(4):572–4. 574Google Scholar
  45. 45.
    Raikou M, McGuire A, Lurz P, Bonhoeffer P, Wegmueller Y. An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J Med Econ. 2011;14(1):47­52.PubMedCrossRefGoogle Scholar
  46. 46.
    McElhinney DB, Bergersen L, Marshall AC. In situ fracture of stents implanted for relief of pulmonary arterial stenosis in patients with congenitally malformed hearts. Cardiol Young. 2008;18:405–14.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Nordmeyer J, Khambadkone S, Coats L, Schievano S, Lurz P, Parenzan G, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115(11):1392–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Nordmeyer J, Coats L, Lurz P, Lee TY, Derrick G, Rees P, et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J. 2008;29:810–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Boudjemline Y, Malekzadeh-Milani S, Patel M, Thambo JB, Bonnet D, Iserin L, et al. Predictors and outcomes of right ventricular outflow tract conduit rupture during percutaneous pulmonary valve implantation: a multicentre study. EuroIntervention. 2016;11(9):1053–62.PubMedCrossRefGoogle Scholar
  50. 50.
    Butera G, Milanesi O, Spadoni I, Piazza L, Donti A, Ricci C, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013;81(2):310–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Suradi HS, Hijazi ZM. Percutaneous pulmonary valve implantation. Glob Cardiol Sci Pract. 2015;2015(2):23.  https://doi.org/10.5339/gcsp.2015.23.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Malekzadeh-Milani S, Ladouceur M, Patel M, Boughenou FM, Iserin L, Bonnet D, et al. Incidence and predictors of melody(R) valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108:97–106.Google Scholar
  53. 53.
    Khanna AD, Hill KD, Pasquali SK, et al. Benchmark outcomes for pulmonary valve replacement using the society of thoracic surgeons databases. Ann Thoracic Surg. 2015;100:138–45.CrossRefGoogle Scholar
  54. 54.
    Feltes TF, Bacha E, Beekman RHIII, JCheatham JP, Feinstein JA, Gomes AS, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2607–52.PubMedCrossRefGoogle Scholar
  55. 55.
    Boshoff DE, Cools BL, Heying R, Troost E, Kefer J, Budts W, et al. Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv. 2013;81:987–95.PubMedCrossRefGoogle Scholar
  56. 56.
    Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovas Magn Reson. 2007;9:687–95.CrossRefGoogle Scholar
  57. 57.
    Boudjemline Y, Brugada G, Van-Aerschot I, Patel M, Basquin A, Bonnet C, et al. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis. 2012;105:404–13.PubMedCrossRefGoogle Scholar
  58. 58.
    Bertels RA, Blom NA, Schalij MJ. Edwards SAPIEN transcatheter heart valve in native pulmonary valve position. Heart. 2010;96:661.PubMedCrossRefGoogle Scholar
  59. 59.
    Boudjemline Y, Agnoletti G, Bonnet D, Bonhoeffer P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract—an experimental study. J Am Coll Cardiol. 2004;43:1082–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Schievano S, Taylor AM, Capelli C, Coats L, Walker F, Lurz P, et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. Eur Secur. 2010;5:745–50.Google Scholar
  61. 61.
    Benson LN. One year outcomes from the early feasibility study of the Harmony transcatheter pulmonary valve. Presented at TCT, 2016.Google Scholar
  62. 62.
    Cao QL, Kenny D, Zhou D, Pan W, Guan L, Ge J, et al. Early clinical experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2014;84:1131–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Promphan W, Prachasilchai P, Siripornpitak S, Qureshi SA, Layangool T. Percutaneous pulmonary valve implantation with the Venus P-valve: clinical experience and early results. Cardiol Young. 2015;19:1–13.Google Scholar
  64. 64.
    Garay F, Pan X, Zhang YJ, Wang C, Springmuller D. Early experience with the Venus p-valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J. 2017;25:76–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Husain J, Praichasilchai P, Gilbert Y, Qureshi SA, Morgan GJ. Early European experience with the Venus P-valve®: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016;12(5):e643–51.PubMedCrossRefGoogle Scholar
  66. 66.
    Kim GB, Kwon BS, Lim HG. First in human experience of a new self-expandable percutaneous pulmonary valve implantation using knitted nitinol-wire and tri-leaflet porcine pericardial valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2017;89(5):906–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862–70.PubMedCrossRefGoogle Scholar
  68. 68.
    Sosnowski C, Matella T, Fogg L, Ilbawi M, Nagaraj H, Kavinsky C, et al. Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: comparison with surgical PVR. Catheter Cardiovasc Interv. 2016;88:804–10.PubMedCrossRefGoogle Scholar
  69. 69.
    Phillips ABM, Nevin P, Shah A, Shah A, Olshove V, Garg R, et al. Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of Fallot. Catheter Cardiovasc Interv. 2016;87:403–10.PubMedCrossRefGoogle Scholar
  70. 70.
    Wilhelm C, Swinning J, Sisk M, Holzer R. Melody valve implantation using a double-balloon “flower-blossom” technique. Cong Cardiol Today. 2014;8:1–8.Google Scholar
  71. 71.
    Violini R, Vairo U, Hijazi ZM. Stent strut breakage using high pressure balloons for bifurcation stenting and subsequent percutaneous pulmonary valve replacement using the Edwards Sapien THV. Catheter Cardiovasc Interv. 2013;82:834–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Maschietto N, Milanesi O. A concert in the heart: bilateral melody valve implantation in the branch pulmonary arteries. J Invasive Cardiol. 2013;25:E69–71.PubMedGoogle Scholar
  73. 73.
    Jalal Z, Malekzadeh-Milani S, Hofbeck M, Al Najashi K, Thambo JB, Boudjemline Y. A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: the “folded melody valve”. Catheter Cardiovasc Interv. 2015;85:604–10.PubMedCrossRefGoogle Scholar
  74. 74.
    Levi DS, Sinha S, Salem MM, Aboulhosn JA. Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: initial experience and development of a new delivery platform. Catheter Cardiovasc Interv. 2016;88(3):434–43.PubMedCrossRefGoogle Scholar
  75. 75.
    DeGiovann J. Transcatheter pulmonary valve replacement. The Edwards Sapien valve. Struct Heart Dis J. 2017;3:62–72.CrossRefGoogle Scholar
  76. 76.
    •• Tretter JT, Friedberg MK, Wald RM, McElhinney DB. Defining and refining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol. 2016;221:916–25. This article provide other indices that can refine the timing of tPVR, such as indices of myocardial wall strain, tissue velocities, diastology, and ventricular response to exercise.PubMedCrossRefGoogle Scholar
  77. 77.
    Armstrong AK, Balzer DT, Cabalka AK, Gray RG, Javois AJ, et al. One-year follow-up of the melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv. 2014;7:1254–62.PubMedCrossRefGoogle Scholar
  78. 78.
    Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32(10):1260–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117(15):1964–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Wail Alkashkari
    • 1
  • Amani Alsubei
    • 1
  • Ziyad M. Hijazi
    • 2
    • 3
  1. 1.King Saud Bin Abdulaziz University For Health Science & King Faisal Cardiac Center, King Abdulaziz Medical City for National GuardJeddahSaudi Arabia
  2. 2.Sidra Cardiac Program, Sidra Medical & Research CenterDohaQatar
  3. 3.Weill Cornell MedicineNew YorkUSA

Personalised recommendations